Genzyme would like to provide a brief update to the global Pompe community related to some recent delays in shipments of Myozyme® (alglucosidase alfa) produced at the 4000 L manufacturing scale in our Geel, Belgium facility. This scale of product currently supplies the majority of countries worldwide and the ATAP program in the United States. These delays were neither related to a supply shortage of Myozyme nor Genzyme’s recent announcement of production issues at the Allston facility, as Myozyme 4000 L is not produced in that facility.
To read full update, please click here (PDF, 28 kB)